| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in treatments for Sjögren's syndrome: the glass is half full
|
Felten, Renaud
|
|
|
|
9 |
p. e516-e518
|
artikel
|
| 2 |
An adult presentation consistent with PIMS-TS
|
Jones, Imogen
|
|
|
|
9 |
p. e520-e521
|
artikel
|
| 3 |
Biosimilars and the era of interchangeability
|
The Lancet Rheumatology,
|
|
|
|
9 |
p. e495
|
artikel
|
| 4 |
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
|
Saxena, Amit
|
|
|
|
9 |
p. e582-e585
|
artikel
|
| 5 |
Calcium pyrophosphate deposition disease moves into the spotlight
|
Dalbeth, Nicola
|
|
|
|
9 |
p. e497-e499
|
artikel
|
| 6 |
Challenges of a stratified care approach to musculoskeletal pain
|
Stanaway, Fiona F
|
|
|
|
9 |
p. e578-e579
|
artikel
|
| 7 |
Clinical and molecular associations with outcomes at 2 years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK)
|
Garriga, Cesar
|
|
|
|
9 |
p. e648-e658
|
artikel
|
| 8 |
Correction to Lancet Rheumatol 2022; 4: e282–92
|
|
|
|
|
9 |
p. e588
|
artikel
|
| 9 |
COVID-19 in children and young people
|
Felsenstein, Susanna
|
|
|
|
9 |
p. e514-e516
|
artikel
|
| 10 |
COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study
|
Zhong, Jixin
|
|
|
|
9 |
p. e557-e564
|
artikel
|
| 11 |
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study
|
Fredi, Micaela
|
|
|
|
9 |
p. e549-e556
|
artikel
|
| 12 |
COVID-19 vaccine data provide reassurance
|
The Lancet Rheumatology,
|
|
|
|
9 |
p. e605
|
artikel
|
| 13 |
Defining COVID-19-associated hyperinflammatory syndrome in specific populations
|
Webb, Brandon J
|
|
|
|
9 |
p. e609-e611
|
artikel
|
| 14 |
Effect of anakinra in COVID-19
|
Kooistra, Emma J
|
|
|
|
9 |
p. e523-e524
|
artikel
|
| 15 |
Effect of anakinra in COVID-19 – Authors' reply
|
Cavalli, Giulio
|
|
|
|
9 |
p. e524-e525
|
artikel
|
| 16 |
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis
|
Maksymowych, Walter P
|
|
|
|
9 |
p. e626-e634
|
artikel
|
| 17 |
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
|
Izadi, Zara
|
|
|
|
9 |
p. e603-e613
|
artikel
|
| 18 |
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial
|
Pascart, Tristan
|
|
|
|
9 |
p. e523-e531
|
artikel
|
| 19 |
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
|
Schreiber, Karen
|
|
|
|
9 |
p. e501-e506
|
artikel
|
| 20 |
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|
|
|
|
|
9 |
p. e508-e522
|
artikel
|
| 21 |
Healing structural damage in axial spondyloarthritis: are we there yet?
|
Proft, Fabian
|
|
|
|
9 |
p. e581-e582
|
artikel
|
| 22 |
How long does a shoulder replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 10 years of follow-up
|
Evans, Jonathan P
|
|
|
|
9 |
p. e539-e548
|
artikel
|
| 23 |
Impact of methotrexate on first-dose COVID-19 mRNA vaccination
|
Connolly, Caoilfhionn M
|
|
|
|
9 |
p. e607-e609
|
artikel
|
| 24 |
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study
|
Simon, David
|
|
|
|
9 |
p. e614-e625
|
artikel
|
| 25 |
Intravenous anakinra for cytokine storm syndromes
|
Martis, Nihal
|
|
|
|
9 |
p. e522
|
artikel
|
| 26 |
Intravenous anakinra for cytokine storm syndromes
|
Jamilloux, Yvan
|
|
|
|
9 |
p. e521-e522
|
artikel
|
| 27 |
Intravenous anakinra for cytokine storm syndromes – Authors' reply
|
Mehta, Puja
|
|
|
|
9 |
p. e522-e523
|
artikel
|
| 28 |
Kanon Jatuworapruk: bringing out the enjoyment in life
|
Thorley, Jennifer
|
|
|
|
9 |
p. e590
|
artikel
|
| 29 |
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
|
Hsu, Tiffany Y-T
|
|
|
|
9 |
p. e638-e647
|
artikel
|
| 30 |
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study
|
Fleischmann, Roy M
|
|
|
|
9 |
p. e532-e541
|
artikel
|
| 31 |
Multiple switching studies and interchangeability of biosimilars
|
Kay, Jonathan
|
|
|
|
9 |
p. e499-e501
|
artikel
|
| 32 |
Pain and wellbeing in young people with arthritis
|
The Lancet Rheumatology,
|
|
|
|
9 |
p. e577
|
artikel
|
| 33 |
Pentazocine-induced fibromyositis: a case of scleroderma mimic
|
Pattnaik, Jigyansa Ipsita
|
|
|
|
9 |
p. e646
|
artikel
|
| 34 |
Potential for false decline of anti-SARS-CoV-2 spike antibody titers after COVID-19 vaccination
|
Waldman, Meryl
|
|
|
|
9 |
p. e586-e587
|
artikel
|
| 35 |
Primary synovial chondromatosis (Reichel Syndrome)
|
Tripathy, Saumya Ranjan
|
|
|
|
9 |
p. e576
|
artikel
|
| 36 |
Reactivation of IgA vasculitis after COVID-19 vaccination
|
Obeid, Michel
|
|
|
|
9 |
p. e617
|
artikel
|
| 37 |
Research in Brief
|
Thorley, Jennifer
|
|
|
|
9 |
p. e589
|
artikel
|
| 38 |
Research in Brief
|
Thorley, Jennifer
|
|
|
|
9 |
p. e618
|
artikel
|
| 39 |
Research in Brief
|
Thorley, Jennifer
|
|
|
|
9 |
p. e526
|
artikel
|
| 40 |
Research in Brief
|
Thorley, Jennifer
|
|
|
|
9 |
p. e507
|
artikel
|
| 41 |
Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative method
|
Paskins, Zoe
|
|
|
|
9 |
p. e635-e645
|
artikel
|
| 42 |
Risk-based stratified primary care for common musculoskeletal pain presentations (STarT MSK): a cluster-randomised, controlled trial
|
Hill, Jonathan C
|
|
|
|
9 |
p. e591-e602
|
artikel
|
| 43 |
Risks and benefits of tocilizumab monotherapy in giant cell arteritis
|
Cid, Maria C
|
|
|
|
9 |
p. e606-e607
|
artikel
|
| 44 |
ROSAH syndrome: childhood-onset arthritis, hand deformities, uveitis, and splenomegaly
|
Lequain, Hippolyte
|
|
|
|
9 |
p. e564
|
artikel
|
| 45 |
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
|
Papp, Kim
|
|
|
|
9 |
p. e542-e552
|
artikel
|
| 46 |
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study
|
Genovese, Mark C
|
|
|
|
9 |
p. e527-e538
|
artikel
|
| 47 |
SARS-CoV-2 vaccine-induced antibody levels: what lies beneath
|
Lassaunière, Ria
|
|
|
|
9 |
p. e579-e581
|
artikel
|
| 48 |
Setting sights and giving thanks
|
The Lancet Rheumatology,
|
|
|
|
9 |
p. e511
|
artikel
|
| 49 |
Severe refractory Kawasaki disease in seven infants in the COVID-19 era
|
Vergnano, Stefania
|
|
|
|
9 |
p. e520
|
artikel
|
| 50 |
Shoulder replacement survivorship
|
Sodhi, Nipun
|
|
|
|
9 |
p. e513-e514
|
artikel
|
| 51 |
Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
|
Crosby, Laura
|
|
|
|
9 |
p. e615-e616
|
artikel
|
| 52 |
Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
|
Talarico, Rosaria
|
|
|
|
9 |
p. e518-e519
|
artikel
|
| 53 |
Tapering of disease-modifying antirheumatic drugs: an overview for daily practice
|
Maassen, Johanna Maria
|
|
|
|
9 |
p. e659-e670
|
artikel
|
| 54 |
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
|
Mahil, Satveer K
|
|
|
|
9 |
p. e627-e637
|
artikel
|
| 55 |
The global burden of osteoarthritis: past and future perspectives
|
Wong, Arnold YL
|
|
|
|
9 |
p. e496-e497
|
artikel
|
| 56 |
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
|
Johnson, Peter A
|
|
|
|
9 |
p. e553-e563
|
artikel
|
| 57 |
Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study
|
Christ, Lisa
|
|
|
|
9 |
p. e619-e626
|
artikel
|
| 58 |
Tolerance-inducing medicines in autoimmunity: rheumatology and beyond
|
Stanway, James A
|
|
|
|
9 |
p. e565-e575
|
artikel
|
| 59 |
Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
|
Felten, Renaud
|
|
|
|
9 |
p. e613-e615
|
artikel
|
| 60 |
Understanding when and how joint injury leads to osteoarthritis
|
Lohmander, L Stefan
|
|
|
|
9 |
p. e611-e612
|
artikel
|
| 61 |
Vagus nerve stimulation for autoimmune rheumatic diseases
|
Ng, Wan-Fai
|
|
|
|
9 |
p. e512-e513
|
artikel
|
Tijdschrift beschrijving